Armistice Capital, LLC 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 9:55 pm Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Armistice Capital, LLC | 0 0.000% |
-2,742,000 (Position Closed) |
Filing |
| 2021-02-16 2:47 pm Purchase |
2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Armistice Capital, LLC | 2,742,000 9.600% |
546,000 (+24.86%) |
Filing |